108 related articles for article (PubMed ID: 3497637)
1. The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac.
Sancilio LF; Nolan JC; Wagner LE; Ward JW
Arzneimittelforschung; 1987 May; 37(5):513-9. PubMed ID: 3497637
[TBL] [Abstract][Full Text] [Related]
2. Bromfenac, a new nonsteroidal anti-inflammatory drug: relationship between the anti-inflammatory and analgesic activity and plasma drug levels in rodents.
Nolan JC; Osman MA; Cheng LK; Sancilio LF
J Pharmacol Exp Ther; 1990 Jul; 254(1):104-8. PubMed ID: 2366177
[TBL] [Abstract][Full Text] [Related]
3. The topical anti-inflammatory and analgesic properties of bromfenac in rodents.
Nolan JC; Wagner LE; Gathright CE; Stephens DJ; Sancilio LF
Agents Actions; 1988 Aug; 25(1-2):77-85. PubMed ID: 3189047
[TBL] [Abstract][Full Text] [Related]
4. [The pharmacologic effect of flupirtine, a structurally new analgesic].
Jakovlev V; Sofia RD; Achterrath-Tuckermann U; von Schlichtegroll A; Thiemer K
Arzneimittelforschung; 1985; 35(1):30-43. PubMed ID: 2985093
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
6. Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties--outline of toxicological and pharmacokinetic data.
Julou L; Guyonnet JC; Ducrot R; Fournel J; Pasquet J
Scand J Rheumatol Suppl; 1976; 1976(0):33-44. PubMed ID: 824723
[TBL] [Abstract][Full Text] [Related]
7. The effect of food on bromfenac, naproxen sodium, and acetaminophen in postoperative pain after orthopedic surgery.
Forbes JA; Sandberg RA; Bood-Björklund L
Pharmacotherapy; 1998; 18(3):492-503. PubMed ID: 9620100
[TBL] [Abstract][Full Text] [Related]
8. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Bucci FA; Waterbury LD
Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Waterbury LD; Silliman D; Jolas T
Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers.
Högger P; Rohdewald P
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):377-85. PubMed ID: 10475140
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal effects and acute toxicity of suprofen.
Niemegeers CJ; Lenaerts FM; Awouters F; Janssen PA
Arzneimittelforschung; 1975 Oct; 25(10):1537-42. PubMed ID: 1243036
[TBL] [Abstract][Full Text] [Related]
12. Analgesic and antiinflammatory effects of 2-(10,11-dihydro-10-oxo-dibenzo[b,f]thiepin-2-yl)propionic acid in rat and mouse.
Kameyama T; Nabeshima T; Yamada S; Sato M
Arzneimittelforschung; 1987 Jan; 37(1):19-26. PubMed ID: 3494460
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological properties of fenbufen. A review.
Sloboda AE; Tolman EL; Osterberg AC; Panagides J
Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Bucci FA; Waterbury LD
Adv Ther; 2011 Dec; 28(12):1089-95. PubMed ID: 22105509
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of bromfenac in healthy subjects after single oral administration of three different doses.
Högger P; Rohdewald P
Arzneimittelforschung; 1993 Oct; 43(10):1114-8. PubMed ID: 8267679
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological studies of dl-2[3-(2'-chlorophenoxy)phenyl]propionic acid. I. Analgesic and antipyretic effects].
Kaneko T; Ozaki S; Ohkawa I; Yamatsu K
Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):481-92. PubMed ID: 6413312
[TBL] [Abstract][Full Text] [Related]
17. Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazone.
Schiantarelli P; Cadel S
Arzneimittelforschung; 1981; 31(1):87-92. PubMed ID: 6971112
[TBL] [Abstract][Full Text] [Related]
18. 2-[3-(1,1-Dimethylethyl)-5-methoxyphenyloxazolo[4,5-b]pyridine, a new topical antiinflammatory and analgesic compound lacking systemic activity and gastric side effects.
Bonney RJ; Olson BJ; Bach T; Beveridge G; Goldenberg MM; Gitterman CO; Humes JL; Lu AY; Hucker H; Dougherty H
Arzneimittelforschung; 1985; 35(4):715-20. PubMed ID: 3874629
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
20. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt.
Rooks WH; Maloney PJ; Shott LD; Schuler ME; Sevelius H; Strosberg AM; Tanenbaum L; Tomolonis AJ; Wallach MB; Waterbury D
Drugs Exp Clin Res; 1985; 11(8):479-92. PubMed ID: 3879752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
